Editorials

Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma

Alexander Chi, Sijin Wen, Nam P. Nguyen, Geraldine Jacobson, Scot Remick, William Tse, Zhongxing Liao

Abstract

Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1).